#ACC24 REDUCE-AMI another blockbuster Beta-blockers with NO reduction in myocardial infarction or death in pts with preserved EF post-MI Massive finding likely with big implications for #Cardiology practice

🌟 Spannende Einblicke vom Leipziger Kardiologengespräch 2024! 🌟 #ACC.24 Kongress-Update im Livestream: webucation.online/herzmedizin/ Mittwoch 10.04. 19:00 h ⁦Herzmedizin.de⁩ ⁦Deutsche Gesellschaft für Kardiologie⁩ ⁦AGIK⁩ ⁦Janine Pöss⁩ ⁦Young DGK⁩ ⁦AGEP⁩ ⁦

📣🚨New #IMPact #podcast episode online 🎧 latest on step-by-step #echofirst #tricuspid #TEER #EHJIMP Julia Grapsa Alessia Gimelli European Society of Cardiology Vladyslav Kavalerchyk 🇺🇦 EACVI President EHJ-IMP Editor-in-Chief Victoria Delgado Shehab Anwer, MD Philipp Lurz Karl-Patrik Kresoja European Society of Cardiology Journals academic.oup.com/ehjimp/pages/p…

☀️🏖️ Der Sommer kommt 🔜 die Summer School kommt! 🗓️ 07. und 08. Juni 2024 📌 Sporthochschule Köln JETZT ANMELDEN & Hotelzimmer vor Ort reservieren ☀️Tipps & Tricks für Klinik & Praxis ☀️ Prävention ☀️ Sportmedizin ☀️ uvm. Deutsche Gesellschaft für Kardiologie Herzmedizin.de Deutsche Herzstiftung #ALKK

Privileged to work on this editorial with Vishal Rao & Ryan J Tedford MD out now in European Journal of Heart Failure European Society of Cardiology Journals Letting go of restraint: Tricuspid valve intervention in heart failure with preserved ejection fraction onlinelibrary.wiley.com/doi/full/10.10…

Congratulations to Karl-Patrik Kresoja Karl-Philipp Rommel Philipp Lurz on this outstanding contribution, teaching us about the complex hemodynamics of TV repair in European Society of Cardiology Journals. doi.org/10.1002/ejhf.3… Our accompanying editorial below.

Good morning #cardiottwitter #EuroPCR 🇫🇷 2024 is about to start 😍 Don’t forget to follow the morning #live from Mainz University with Philipp Lurz & M.Geyer on #TAVR #mainzinthecenteroftheheart #eapci Univ.-Prof. Dr. Ralph Stephan von Bardeleben PCRonline 🫀 MIЯVΛƬ #IC pcronline.com/Courses/EuroPC

TR Fundamentals for early birds #NYValves2024 now in the Main Arena! Great insights on RV/RA physiology and role of EP docs in the TR patient selection Philipp Lurz Paul Grayburn Karl-Philipp Rommel Karl-Patrik Kresoja Sara Bombace Cardiovascular Research Foundation Julia Grapsa

Don’t forget to join here 10/6 at 15:00 CEST 🫀 Get to know #EHJIM Alessia Gimelli EHJ-IMP Editor-in-Chief Edoardo Zancanaro MD Julia Grapsa #EACVI Steffen Petersen Victoria Delgado EACVI President European Society of Cardiology Journals @GeraldMaurer Denisa Muraru Sara Ersözlü, MD Andreas Giannopoulos Dominik C. Benz Dr Anastasia Mihailidou FAHA FCSANZ FESC Ritu Thamman MD

#EACVI Steffen Petersen Victoria Delgado EACVI President European Society of Cardiology Journals @GeraldMaurer Denisa Muraru Sara Ersözlü, MD Andreas Giannopoulos Dominik C. Benz Dr Anastasia Mihailidou FAHA FCSANZ FESC Ritu Thamman MD Philipp Lurz Vladyslav Kavalerchyk 🇺🇦 Karl-Patrik Kresoja rafavidalperez RTHahnMD

Ever wondered how a #lncRNA can regulate monocytes towards an #antiinflammatory phenotype & promote #vascularhealing? Read our study on the CVD-regulated lncRNA #HEAT4 & learn how S100A9 is involved: 👉 ahajournals.org/doi/10.1161/CI… Jasmin M. Kneuer Kudos to all authors& DrawImpacts 🎨

Finerenone meets primary endpoint in Phase III FINEARTS-HF🎉 ❤️ expanded treatment options for HFpEF! —> to be presented at ESC ‼️pending: the SPIRRT HFPEF trial with MRA ⁦Duke Clinical Research Institute⁩ ⁦Karolinska Institutet⁩ ⁦Uppsala University⁩ ⁦NIH NHLBI⁩ bayer.com/media/en-us/fi…

#JoinUS at #TeamUM for the 11th #Mainz #Heartvalve Symposium August 6-7, 2024 with latest trial data and past president of #DGK Prof Stephan Baldus see U there ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ linkedin.com/posts/von-bard…

Benefit of isolated surgical valve repair or replacement for functional #TricuspidRegurgitation and long-term outcomes stratified by the #TRISCORE released at #ESCCongress and just published in #EHJ👉 bit.ly/4g6TR0b EHJ Editor-in-Chief Dreyfus Julien Fernando M. Juarez-Casso

🔥#FINEARTS a win for #HFpEF - Reduction in HFH 🏨 and trend for ☠️ ⬇️ - Yet again, no signal in HFpEF&LVEF >60% - what's the deal with those ef>60% and high NT-proBNP level guys anyway? Philipp Lurz Holger Thiele Univ.-Prof. Dr. Ralph Stephan von Bardeleben Erik Rafflenbeul Marco Metra Karl-Philipp Rommel #ESC2024

supranormal ejection fraction HFpEF different entity with distinct pathophysiology and afterload and systolic stiffness/hypercontractility as disease drivers rather than fibrosis, just at the beginning here…

So happy to see our newly developed SEX-SHOCK score now up in the EHJ Editor-in-Chief, published simultaneously with the #ESCCongress. 👉 doi.org/10.1093/eurhea… 👉 A/I-based calculator: mdcalc.com/calc/10563/sex… Lorenz Räber, MD PhD Konstantinos Stellos, MD Luca Liberale Ste_MNS David Niederseer CardioTomLuscher

11. Mainzer Herzklappensymposium - spannender Vortrag zur live MPR Tobias Ruf Univ.-Prof. Dr. Ralph Stephan von Bardeleben Philipp Lurz Julian Schmeißer Karl-Philipp Rommel Karl-Patrik Kresoja #echofirst